Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 4Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Breast Neoplasms 76Carcinoma, Non-Small-Cell Lung 73Multiple Myeloma 58Prostatic Neoplasms 57Colorectal Neoplasms 45Leukemia, Myeloid, Acute 43Neoplasms 41Melanoma 35Lymphoma 35Lung Neoplasms 32Ovarian Neoplasms 31Lymphoma, Non-Hodgkin 30Squamous Cell Carcinoma of Head and Neck 29Sarcoma 28Neoplasm Metastasis 27Pancreatic Neoplasms 26Endometrial Neoplasms 25Carcinoma, Hepatocellular 25Hodgkin Disease 23Carcinoma, Renal Cell 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Large B-Cell, Diffuse 22Leukemia, Lymphocytic, Chronic, B-Cell 22Glioma 22Recurrence 21Urinary Bladder Neoplasms 20Myelodysplastic Syndromes 20Head and Neck Neoplasms 20Esophageal Neoplasms 17Stomach Neoplasms 16

Interventions

cemiplimab 2avelumab 1Radiotherapy 1Nivolumab 1Ipilimumab 1Cryosurgery 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Skin Neoplasms × 30 days × Clear all
NCT03944941 2026-06-02

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
60 enrolled 19 charts
Dermatologic

Skin Neoplasms

NCT04315701 2026-06-01

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

University of Southern California

Phase 2 Active not recruiting
35 enrolled
Dermatologic

Skin Neoplasms

NCT05779423 2026-05-19

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Massachusetts General Hospital

Phase 2 Recruiting
37 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05574101 2026-05-15

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
34 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡